UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Tamoxifen and pregnancy: an absolute contraindication?

Breast cancer research and treatment, 2019-05, Vol.175 (1), p.17-25

2019

Volltextzugriff (PDF)

Deep learning body-composition analysis of clinically acquired CT-scans estimates creatinine excretion with high accuracy in patients and healthy individuals

Scientific reports, 2022-05, Vol.12 (1), p.9013-9013, Article 9013

2022

Volltextzugriff (PDF)

Association Analysis of Genetic Polymorphisms in Genes Related to Sunitinib Pharmacokinetics, Specifically Clearance of Sunitinib and SU12662

Clinical pharmacology and therapeutics, 2014-07, Vol.96 (1), p.81-89

2014

Volltextzugriff (PDF)

Strategies to target drugs to gliomas and CNS metastases of solid tumors

Journal of Neurology, 2016-03, Vol.263 (3), p.428-440

2016

Volltextzugriff (PDF)

Quantification of protease inhibitors and non-nucleoside reverse transcriptase inhibitors in dried blood spots by liquid chromatography–triple quadrupole mass spectrometry

Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 2008-05, Vol.867 (2), p.205-212

2008

Volltextzugriff (PDF)

Pharmacodynamic modeling of adverse effects of anti-cancer drug treatment

European journal of clinical pharmacology, 2016-06, Vol.72 (6), p.645-653

2016

Volltextzugriff (PDF)

Clinical Pharmacokinetics of Vemurafenib in BRAF‐Mutated Melanoma Patients

Journal of clinical pharmacology, 2017-01, Vol.57 (1), p.125-128

2017

Volltextzugriff (PDF)

The cycle effect quantified: reduced tumour uptake in subsequent cycles of [177Lu]Lu-HA-DOTATATE during peptide receptor radionuclide therapy

European journal of nuclear medicine and molecular imaging, 2024-02, Vol.51 (3), p.820-827

2024

Volltextzugriff (PDF)

A real or apparent decrease in glomerular filtration rate in patients using olaparib?

European journal of clinical pharmacology, 2021-02, Vol.77 (2), p.179-188

2021

Volltextzugriff (PDF)

Pharmacokinetics of oseltamivir carboxylate in critically ill patients: each patient is unique

Intensive care medicine, 2013-05, Vol.39 (5), p.977-978

2013

Volltextzugriff (PDF)

Exposure–response analyses of abiraterone and its metabolites in real-world patients with metastatic castration-resistant prostate cancer

Prostate cancer and prostatic diseases, 2020-06, Vol.23 (2), p.244-251

2020

Volltextzugriff (PDF)

Phase I and pharmacological trial of lapatinib in combination with gemcitabine in patients with advanced breast cancer

Investigational new drugs, 2015-12, Vol.33 (6), p.1197-1205

2015

Volltextzugriff (PDF)

Optimizing anticancer drug treatment in pregnant cancer patients: pharmacokinetic analysis of gestation-induced changes for doxorubicin, epirubicin, docetaxel and paclitaxel

Annals of oncology, 2014-10, Vol.25 (10), p.2059-2065

2014

Volltextzugriff (PDF)

Development and validation of a liquid chromatography–tandem mass spectrometry analytical method for the therapeutic drug monitoring of eight novel anticancer drugs

Biomedical chromatography, 2018-04, Vol.32 (4), p.n/a

2018

Volltextzugriff (PDF)

Exposure–response analyses of BRAF- and MEK-inhibitors dabrafenib plus trametinib in melanoma patients

Cancer chemotherapy and pharmacology, 2023-06, Vol.91 (6), p.447-456

2023

Volltextzugriff (PDF)

Gene polymorphisms, pharmacokinetics, and hematological toxicity in advanced non-small-cell lung cancer patients receiving cisplatin/gemcitabine

Cancer chemotherapy and pharmacology, 2012, Vol.69 (1), p.25-33

2012

Volltextzugriff (PDF)

Pharmacokinetically guided sunitinib dosing: a feasibility study in patients with advanced solid tumours

British journal of cancer, 2014-05, Vol.110 (10), p.2441-2449

2014

Volltextzugriff (PDF)

Safety and pharmacology of gemcitabine and capecitabine in patients with advanced pancreatico-biliary cancer and hepatic dysfunction

Cancer chemotherapy and pharmacology, 2014, Vol.73 (1), p.113-124

2014

Volltextzugriff (PDF)

Efficacy and toxicity of vemurafenib and cobimetinib in relation to plasma concentrations, after administration via feeding tube in patients with BRAF-mutated thyroid cancer: a case series and review of literature

Cancer chemotherapy and pharmacology, 2022-07, Vol.90 (1), p.97-104

2022

Volltextzugriff (PDF)

Germline TYMS genotype is highly predictive in patients with metastatic gastrointestinal malignancies receiving capecitabine-based chemotherapy

Cancer chemotherapy and pharmacology, 2015-04, Vol.75 (4), p.763-772

2015

Volltextzugriff (PDF)

The use of microtracers in food‐effect trials: An alternative study design for toxic drugs with long half‐lives exemplified by the case for alectinib

Clinical and translational science, 2023-12, Vol.16 (12), p.2557-2564

2023

Volltextzugriff (PDF)

Development and validation of a quantitative assay for the measurement of two HIV-fusion inhibitors, enfuvirtide and tifuvirtide, and one metabolite of enfuvirtide (M-20) in human plasma by liquid chromatography–tandem mass spectrometry

Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 2006-06, Vol.837 (1), p.49-58

2006

Volltextzugriff (PDF)

An Antiestrogenic Activity Score for tamoxifen and its metabolites is associated with breast cancer outcome

Breast cancer research and treatment, 2017-02, Vol.161 (3), p.567-574

2017

Volltextzugriff (PDF)

Pharmacokinetics and Clinical Efficacy of Phenobarbital in Asphyxiated Newborns Treated with Hypothermia: A Thermopharmacological Approach

Clinical pharmacokinetics, 2012-10, Vol.51 (10), p.671-679

2012

Volltextzugriff (PDF)

The performance of model-based versus rule-based phase I clinical trials in oncology: A quantitative comparison of the performance of model-based versus rule-based phase I trials with molecularly targeted anticancer drugs over the last 2 years

Journal of Pharmacokinetics and Pharmacodynamics, 2016-06, Vol.43 (3), p.235-242

2016

Volltextzugriff (PDF)

1 – 25 von 671

Suche als RSS-Feed

Aktive Filter

SpracheEnglisch

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(646)
Mit Volltextzugriff
(572)

Publikationsform

Artikel
(667)
Tagungsberichte
(4)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

MEDLINE
(466)
Journals@Ovid Full Text
(388)
EZB Electronic Journals Library
(273)
Ingenta
(268)
SpringerLink
(185)
NUS Single-Journal Subscriptions
(129)
IngentaConnect Journals
(128)
Wiley
(122)
SpringerLINK Contemporary (Konsortium Baden-Württemberg)
(99)
Elsevier ScienceDirect Journals Complete
(93)
Elsevier Journal Backfiles on ScienceDirect (DFG Nationallizenzen)
(87)
Wiley Online Library
(87)
Nexis Uni
(79)
Springer Nature - Connect here FIRST to enable access
(21)
SAGE Journals
(21)
Taylor & Francis Journals
(16)
Taylor & Francis
(15)
Oxford journals
(14)
Oxford Journals 2020 Medicine
(13)
Taylor & Francis Online
(11)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(6)

Menü

Weitere Dienste

Einstellungen

Tamoxifen and pregnancy: an absolute contraindication?

Deep learning body-composition analysis of clinically acquired CT-scans estimates creatinine excretion with high accuracy in patients and healthy individuals

Association Analysis of Genetic Polymorphisms in Genes Related to Sunitinib Pharmacokinetics, Specifically Clearance of Sunitinib and SU12662

Strategies to target drugs to gliomas and CNS metastases of solid tumors

Quantification of protease inhibitors and non-nucleoside reverse transcriptase inhibitors in dried blood spots by liquid chromatography–triple quadrupole mass spectrometry

Pharmacodynamic modeling of adverse effects of anti-cancer drug treatment

Clinical Pharmacokinetics of Vemurafenib in BRAF‐Mutated Melanoma Patients

The cycle effect quantified: reduced tumour uptake in subsequent cycles of [177Lu]Lu-HA-DOTATATE during peptide receptor radionuclide therapy

A real or apparent decrease in glomerular filtration rate in patients using olaparib?

Pharmacokinetics of oseltamivir carboxylate in critically ill patients: each patient is unique

Exposure–response analyses of abiraterone and its metabolites in real-world patients with metastatic castration-resistant prostate cancer

Phase I and pharmacological trial of lapatinib in combination with gemcitabine in patients with advanced breast cancer

Optimizing anticancer drug treatment in pregnant cancer patients: pharmacokinetic analysis of gestation-induced changes for doxorubicin, epirubicin, docetaxel and paclitaxel

Development and validation of a liquid chromatography–tandem mass spectrometry analytical method for the therapeutic drug monitoring of eight novel anticancer drugs

Exposure–response analyses of BRAF- and MEK-inhibitors dabrafenib plus trametinib in melanoma patients

Gene polymorphisms, pharmacokinetics, and hematological toxicity in advanced non-small-cell lung cancer patients receiving cisplatin/gemcitabine

Pharmacokinetically guided sunitinib dosing: a feasibility study in patients with advanced solid tumours

Safety and pharmacology of gemcitabine and capecitabine in patients with advanced pancreatico-biliary cancer and hepatic dysfunction

Efficacy and toxicity of vemurafenib and cobimetinib in relation to plasma concentrations, after administration via feeding tube in patients with BRAF-mutated thyroid cancer: a case series and review of literature

Germline TYMS genotype is highly predictive in patients with metastatic gastrointestinal malignancies receiving capecitabine-based chemotherapy

The use of microtracers in food‐effect trials: An alternative study design for toxic drugs with long half‐lives exemplified by the case for alectinib

Development and validation of a quantitative assay for the measurement of two HIV-fusion inhibitors, enfuvirtide and tifuvirtide, and one metabolite of enfuvirtide (M-20) in human plasma by liquid chromatography–tandem mass spectrometry

An Antiestrogenic Activity Score for tamoxifen and its metabolites is associated with breast cancer outcome

Pharmacokinetics and Clinical Efficacy of Phenobarbital in Asphyxiated Newborns Treated with Hypothermia: A Thermopharmacological Approach

The performance of model-based versus rule-based phase I clinical trials in oncology: A quantitative comparison of the performance of model-based versus rule-based phase I trials with molecularly targeted anticancer drugs over the last 2 years

Aktive Filter

Suchergebnisse filtern